» Articles » PMID: 3004028

MPLV: a Retrovirus Complex Inducing an Acute Myeloproliferative Leukemic Disorder in Adult Mice

Overview
Journal Virology
Specialty Microbiology
Date 1986 Mar 1
PMID 3004028
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

A novel murine retrovirus complex was derived from the in vivo passage of a molecularly cloned Friend ecotropic helper virus. The virus isolate, myeloproliferative leukemia virus (MPLV), causes an acute (2-3 weeks) and generalized myeloproliferative disorder in adult mice. All strains of mice examined, including the C57BL/6J strain, developed the acute syndrome. This syndrome is characterized by a rapid hepatosplenomegaly, no thymus or lymph node involvement, granulocytosis, thrombocytosis, and erythroblastosis leading to polycythemia. The most prominent feature at the terminal phase of the disease is a granulocytic hyperplasia. The MPLV isolate replicates in vitro on NIH 3T3 fibroblasts but does not induce foci of transformed cells. Thus, MPLV exhibits unique biological properties that distinguish it either from the Friend virus complexes or from acutely transforming sarcomatogenic murine retrovirus which also induced a rapid splenomegaly.

Citing Articles

A review on the functional characteristics of the c-Myeloproliferative Leukaemia (c-MPL) gene and its isoforms.

Hussain M, Das S, Kulkarni M, Laha S Cell Oncol (Dordr). 2024; 47(5):1607-1626.

PMID: 39283476 DOI: 10.1007/s13402-024-00988-w.


Thrombopoietin, the Primary Regulator of Platelet Production: From Mythos to Logos, a Thirty-Year Journey.

Kaushansky K Biomolecules. 2024; 14(4).

PMID: 38672505 PMC: 11047867. DOI: 10.3390/biom14040489.


PEGylated thrombopoietin mimetic, JNJ‑26366821 a novel prophylactic radiation countermeasure for acute radiation injury.

Holmes-Hampton G, Kumar V, Biswas S, Stone S, Sharma N, Legesse B Sci Rep. 2023; 13(1):15211.

PMID: 37709916 PMC: 10502090. DOI: 10.1038/s41598-023-42443-0.


The thrombopoietin receptor: revisiting the master regulator of platelet production.

Hitchcock I, Hafer M, Sangkhae V, Tucker J Platelets. 2021; 32(6):770-778.

PMID: 34097561 PMC: 8292222. DOI: 10.1080/09537104.2021.1925102.


The Thrombopoietin Receptor, MPL, Is a Therapeutic Target of Opportunity in the MPN.

Spivak J, Moliterno A Front Oncol. 2021; 11:641613.

PMID: 33777803 PMC: 7987816. DOI: 10.3389/fonc.2021.641613.